Home/Celularity/Robert J. Hariri
RJ

Robert J. Hariri

Chairperson, Founder, and Chief Executive Officer

Celularity

Celularity Pipeline

DrugIndicationPhase
Placental-derived biomaterial productsWound care / Tissue regenerationApproved/Commercial
MLASC-based therapiesDegenerative DiseasesPhase 1/2
NK Cell therapiesOncologyPhase 1/2
T Cell therapiesImmunology/OncologyPhase 1/2